1
CARDIOVASCULAR
hamburger

Close the Gap

Welcome to a Virtual HRS Experience from Abbott!

We hope you are staying safe during these trying times. Abbott is your partner and we are committed to supporting you. With the cancellation of the 2020 Heart Rhythm Scientific Sessions due to COVID-19, we know having access to the latest clinical information is still important. We would like to share with you recent publications and data from your peers, in addition to Rhythm Theater presentations from your electrophysiology colleagues.


New Presentations - HRS 2020 Science Rhythm Theater

Abbott is offering on-demand Rhythm Theaters that feature presentations from your peers, now available on the HRS 2020 Science Industry content website:

  • Prof. Isabel Deisenhofer, Prof. Daniel Steven, Prof. Paolo Della Bella: Review of Advanced Arrhythmia Mapping
  • Drs. Frédéric Sebag and Lukas Dekker: PVI Gap Identification Using a High Density Grid-Style Catheter: Results from Multi-Center Data Collection
  • Dr. Takanori Yamaguchi and Prof. Peter Kistler: Advancements in High Density Mapping Technologies in Atrial Arrhythmias: First global cases performed utilizing EnSite™ LiveView Dynamic Display reviewed.
  • Dr. John Day and Prof. Daniel Steven: PVI Gap Identification Using a High Density Grid-Style Catheter: Long-Term Outcomes & Commentary

Presentations are now available for on-demand viewing—please search by title to find the above presentations.


New Data Released Comparing Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ to Standard Pulmonary Vein Isolation Confirmation Workflows

After much anticipation, the European Society of Cardiology (ESC) has released all three abstracts accepted to EHRA 2020, related to use of the Advisor HD Grid Mapping Catheter, SE for identification of gaps during PVI. See below for a summary of the data and presentations from your peers discussing the findings.

  • Circular Mapping Catheters1

    The incidence and location of gaps following PVI were tracked utilizing either a 10-pole circular mapping catheter (CMC10), a 20-pole circular mapping catheter (CMC20) or the Advisor™ HD Grid Mapping Catheter, SE.

    Isolation Was Tracked Across 99 Cases
  • Cryoablation2

    In a direct comparison, 18 patients received cryoablation with isolation confirmed by the Achieve Mapping Catheter. Isolation was then checked again with the Advisor HD Grid Mapping Catheter, SE, revealing:

    4 patients with ≥ 1 gap missed by the Achieve Mapping Catheter

    12 total gaps missed by the Achieve mapping catheter were identified by the Advisor HD Grid Mapping Catheter, SE2
  • Pacing Ablation Line3

    In a direct comparison, 22 patients received ablation with isolation confirmed by pacing the ablation line. Isolation was then checked again with the Advisor HD Grid Mapping Catheter, SE, revealing:

    15 patients with ≥ 1 gap missed by pacing3
    30 total gaps missed by pacing were identified by the advisor HD Grid Mapping Catheter, SE3

Physician Presentations

Comparison of Gap Identification Using Three Technologies for Confirmation of Pulmonary Vein Isolation

Dr. Frédéric Sebag (Paris, France)

Dr. Frédéric Sebag (Paris, France) discusses the Comparison of Gap Identification Using Three Technologies for Confirmation of Pulmonary Vein Isolation.

Incidence and Location of PVI Gaps Identified Post-Cryoballoon Ablation for Atrial Fibrillation

Dr. Zayd Eldadah (Washington, D.C., U.S.A.)

Dr. Zayd Eldadah (Washington, D.C., U.S.A.) discusses the Incidence and Location of PVI Gaps Identified Post-Cryoballoon Ablation for Atrial Fibrillation.

Comparison of Gap Identification Using Three Technologies for Confirmation of Pulmonary Vein Isolation

Prof. Daniel Steven (Cologne, Germany)

Prof. Daniel Steven (Cologne, Germany) discusses the Incidence and Location of Residual Gaps Identified by a High-Density Grid-Style Mapping Catheter after PVI is Confirmed by Pacing the Ablation Line.

Abbott is committed to breakthrough innovations that change people’s lives. We’re pushing the boundaries of technology to preserve, repair and restore hearts. Our focus is to provide the most sophisticated, least invasive cardiovascular tools—devices, monitors and treatments- to help patients like never before. This is life-changing technology at the heart of care.

References
  1. Porterfield C, et al. Comparison of Gap Identification Using Three Technologies for Confirmation of Pulmonary Vein Isolation. Originally scheduled for poster presentation at EHRA 2020 Congress. Abbott. Data on File: MAT-2002108 v1.0.
  2. Eldadah Z, et al. Incidence and Location of PVI Gaps Identified Post-Cryoballoon Ablation for Atrial Fibrillation. Originally scheduled for poster presentation at EHRA 2020 Congress. Abbott. Data on File: MAT-2002103 v1.0.
  3. Giuggia M, et al. Incidence and Location of Residual Gaps Identified by a High-Density Grid-Style Mapping Catheter After PVI Is Confirmed by Pacing the Ablation Lines. Originally scheduled for poster presentation at EHRA 2020 Congress. Abbott. Data on File: MAT-2002112 v1.0.
Disclaimer

This program is not part of HRS 2020 Science as planned by the Heart Rhythm Society Scientific Sessions Program Committee. This event is neither sponsored nor endorsed by the Heart Rhythm Society. This event does not qualify for continuing medical education (CME) credit.

CAUTION: This product is intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at manuals.sjm.com or eifu.abbottvascular.com for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

United States — Required Safety Information | Indications: The Advisor™ HD Grid Mapping Catheter, Sensor Enabled™, is indicated for multiple electrode electrophysiological mapping of cardiac structures in the heart, i.e., recording or stimulation only. This catheter is intended to obtain electrograms in the atrial and ventricular regions of the heart. Contraindications: The catheter is contraindicated for patients with prosthetic valves and patients with left atrial thrombus or myxoma, or interatrial baffle or patch via transseptal approach. This device should not be used with patients with active systemic infections. The catheter is contraindicated in patients who cannot be anticoagulated or infused with heparinized saline. Warnings: Cardiac catheterization procedures present the potential for significant x-ray exposure, which can result in acute radiation injury as well as increased risk for somatic and genetic effects, to both patients and laboratory staff due to the x-ray beam intensity and duration of the fluoroscopic imaging. Careful consideration must therefore be given for the use of this catheter in pregnant women. Catheter entrapment within the heart or blood vessels is a possible complication of electrophysiology procedures. Vascular perforation or dissection is an inherent risk of any electrode placement. Careful catheter manipulation must be performed in order to avoid device component damage, thromboembolism, cerebrovascular accident, cardiac damage, perforation, pericardial effusion, or tamponade. Risks associated with electrical stimulation may include, but are not limited to, the induction of arrhythmias, such as atrial fibrillation (AF), ventricular tachycardia (VT) requiring cardioversion, and ventricular fibrillation (VF). Catheter materials are not compatible with magnetic resonance imaging (MRI). Precautions: Maintain an activated clotting time (ACT) of greater than 300 seconds at all times during use of the catheter. This includes when the catheter is used in the right side of the heart. To prevent entanglement with concomitantly used catheters, use care when using the catheter in the proximity of the other catheters. Maintain constant irrigation to prevent coagulation on the distal paddle. Inspect irrigation tubing for obstructions, such as kinks and air bubbles. If irrigation is interrupted, remove the catheter from the patient and inspect the catheter. Ensure that the irrigation ports are patent and flush the catheter prior to re-insertion. Always straighten the catheter before insertion or withdrawal. Do not use if the catheter appears damaged, kinked, or if there is difficulty in deflecting the distal section to achieve the desired curve. Do not use if the catheter does not hold its curve and/or if any of the irrigation ports are blocked. Catheter advancement must be performed under fluoroscopic guidance to minimize the risk of cardiac damage, perforation, or tamponade.

™ Indicates a trademark of the Abbott group of companies.

‡ Indicates a third party trademark, which is property of its respective owner.

IMPORTANT SAFETY INFORMATION

EnSite Precision™ Cardiac Mapping System

Indications for Use

Use in accordance with the EnSite Precision™ Cardiac Mapping System Indications for Use.

Contraindications

There are no known contraindications.

Warnings

A Warning indicates a risk of a situation which, if not avoided, could result in death or serious injury to the patient or user. Refer to the EnSite Precision™ Cardiac Mapping System Instructions for Use (IFU).

Precautions

CAUTION: A Caution indicates a risk of a situation which, if not avoided, could result in minor or moderate injury to the patient or user or damage to the equipment. Refer to the EnSite Precision™ Cardiac Mapping System IFU.

MAT-2003442 v6.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.